Inhibition of mineralocorticoid activity by the β isoform of the human glucocorticoid receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 60, Issue 1-2, 1997, Pages 43-50

  Bamberger, Christoph M ^a   Bamberger, Ana Maria ^a   Wald, Martin ^a   Chrousos, George P ^b   Schulte, Heinrich M ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LUCIFERASE; MINERALOCORTICOID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HUMAN; KIDNEY CELL; MONKEY; NONHUMAN; PLASMID; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANIMALS; COS CELLS; DEXAMETHASONE; HUMANS; KIDNEY; LIVER; LUCIFERASES; POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0030981591     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00167-7     Document Type: Article

References (39)

1. Orth D. N., Kovacs W. J. and De Bold C. R.: The adrenal cortex. In William's Textbook of Endocrinology (Edited by Wilson J. D. and Foster D. W.). Saunders, Philadelphia, PA (1992) pp. 489-620.
2. Funder J. W.: Mineralocorticoid receptors and hypertension. J. Steroid Biochem. Molec. Biol. 53 (1995) 53-55.
3. Bahr V., Sander-Bahr C., Ardevol R., Tuchelt H., Beland B. Oelkers W.: Effects of natriuretic factor on the renin-aldosterone system: in vivo and in vitro studies. J. Steroid Biochem. Molec. Biol. 45 (1993) 173-178.
4. Arriza J. L., Weinberger C., Cerelli G., Glaser T. M., Handelin B. L., Housman D. E. and Evans R. M.: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275.
5. Evans R. M.: The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895.
6. Beato M., Herrlich P. and Schütz G.: Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857.
7. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. and Evans R. M.: The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839.
8. Rafestin-Oblin M.-E., Couette B., Lombes M. and Baulieu E.-E.: Biochemical studies of the mineralocorticoid receptor: oligomeric structure and anti-hormone action. In Aldosterone: Fundamental Aspects (Edited by Bonvalet F., Lombes M. and Rafestin-Oblin M. E.). Colloque INSERM/John Libbey Eurotext (1991) pp. 55-64.
9. Caamano C. A., Morano M. I., Patel P. D., Watson S. J. and Akil H.: A bacterially expressed mineralocorticoid receptor is associated in vitro with the 90-kilodalton heat shock protein and shows typical hormone- and DNA-binding characteristics. Biochemistry 32 (1993) 8589-8595.
10. Robertson N. M., Schulman G., Karnik S., Alnemri E. and Litwack G.: Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy. Molec. Endocr. 7 (1993) 1226-1239.
11. Lombes M., Binart N., Delahaye F., Baulieu E.-E. and Rafestin-Oblin M. E.: Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists. Biochem J. 302 (1994) 191-197.
12. Alnemri E. S., Maksymowych A. B., Robertson N. M. and Litwack G.: Overexpression and characterization of the human mineralocorticoid receptor. J. Biol. Chem. 266 (1991) 18072-18081.
13. Binart N., Lombes M., Rafestin-Oblin M. E. and Baulieu E.-E.: Characterization of human mineralocorticoidsteroid receptor expressed in a baculovirus system. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10681-10685.
14. Lombes M., Binart N., Oblin M.-E., Joulin V. and Baulieu E. E.: Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements. Biochem. J. 292 (1993) 577-583.
15. Onate S. A., Tsai S. Y., Tsai M.-J. and O'Malley B. W.: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357.
16. Trapp T., Rupprecht R., Castren M., Reul J. M. and Holsboer F.: Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 13 (1994) 1457-1462.
17. Liu W., Wang J., Sauter N. K. and Pearce D.: Steroid receptor heterodimerization in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12480-12848.
18. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R., Thompson E. B., Rosenfeld M. G. and Evans R. M.: Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635-641.
19. Eno I. J. and Detera-Wadleigh S. D.: The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266 (1991) 7182-7188.
20. Bamberger C. M., Bamberger A.-M., De Castro M. and Chrousos G. P.: Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95 (1995) 2435-2441.
21. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M. and Danielsen M.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7413-7417.
22. Brasier A. R., Tate J. E. and Habener J. F.: Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7 (1989) 1116-1122.
23. Rupprecht R., Arriza J. L., Spengler D., Reul J. M., Evans R. M., Holsboer F. and Damm K.: Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Molec. Endocr. 7 (1993) 597-603.
24. Govindan M. V., Leclerc S., Roy R., Rathanaswami P. and Xie B.: Differential regulation of mouse mammary tumor virus-bacterial chloramphenicol acetyltransferase chimeric gene by human mineralocorticoid hormone-receptor complexes. J. Steroid Biochem. Molec. Biol. 39 (1991) 91-103.
25. Zilliacus J., Wright A. P. H., Carlstedt-Duke J. and Gustafsson J.-A.: Structural determinants of DNA-binding specificity by steroid receptors. Molec. Endocr. 9 (1995) 389-400.
26. Arriza J. L., Simerly R. B., Swanson L. W. and Evans R. M.: The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1 (1988) 887-900.
27. Lombes M., Kenouch S., Souque A., Farman N. and Rafestin-Oblin M.-E.: The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11beta-hydroxysteroid dehydrogenase. Endocrinology 135 (1994) 834-840.
28. Funder J. W., Pearce P. T., Smith R. and Smith A. I.: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585.
29. Albiston A. L., Obeyesekere V. R., Smith R. E. and Krozowski Z. S.: Cloning and tissue distribution of the human beta-hydroxysteroid dehydrogenase type 2 enzyme. Molec. Cell Endocr. 105 (1994) R11-R17.
30. Funder J. W.: Enzymes and receptors: challenges and future directions. Steroids 59 (1994) 164-169.
31. van Ekelen J. A. M., Jiang W., de Kloet E. R. and Bohn M. C.: Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J. Neurosci. Res. 21 (1988) 88-94.
32. de Kloet E. R.: Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocr. 12 (1991) 95-164.
33. De Castro M., Elliot S., Kino T., Bamberger C. M., Karl M., Webster E. and Chrousos G. P.: The non-ligand-binding β-iso-form of the human glucocorticoid receptor (hGRβ): tissue levels, mechanism of action, and potential physiological role. Mol. Med. 2 (1996) 597-607.
34. Arai K., Tsigos C., Suzuki Y., Irony I., Karl M., Listwak S. Chrousos G. P.: Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J. Clin. Endocr. Metab. 79 (1994) 1019-1023.
35. Komesaroff P. A., Verity K. and Fuller P. J.: Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor. J. Clin. Endocr. Metab. 79 (1994) 27-31.
36. Zennaro M. C., Borensztein P., Jeunemaitre X., Armanini D. Soubrier F.: No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J. Clin. Endocr. Metab. 79 (1994) 32-38.
37. Arai K., Tsigos C., Suzuki Y., Listwak S., Zachman K., Zangeneh F., Rapaport R., Chanoine J. P. and Chrousos G. P.: No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J. Clin. Endocr. Metab. 80 (1995) 814-817.
38. Chang S. S., Grunder S., Hanukoglu A., Rosler A., Mathew P. M., Hanukoglu I., Schild L., Lu Y., Shimkets R. A., Nelson-Williams C., Rossier B. C. and Lifton R. P.: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I. Nature Genet. 12 (1996) 248-253.
39. Panarelli M. and Fraser R.: The glucocorticoid receptor and hypertension. Endocr. Res. 20 (1994) 101-116.